Markets:

Overview

News

Currencies

International

Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

563.01 -5.84 (-1.03%)

Streaming Delayed Price Updated: 10:32 AM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Medpace Holdings, Inc. Reports Third Quarter 2025 Results

October 22, 2025

From Medpace Holdings, Inc.

Via Business Wire

Preview: Medpace Hldgs's Earnings ↗

October 21, 2025

Via Benzinga

Medpace (MEDP) Reports Earnings Tomorrow: What To Expect

October 20, 2025

Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results this Wednesday afternoon. Here’s what to expect.

Via StockStory

1 High-Flying Stock to Research Further and 2 That Underwhelm

October 17, 2025

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices,...

Via StockStory

Topics Supply Chain

Earnings Scheduled For October 22, 2025 ↗

October 22, 2025

Via Benzinga

1 Volatile Stock Worth Investigating and 2 That Underwhelm

October 13, 2025

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

Via StockStory

Medpace and Revvity Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

3 Market-Beating Stocks with Competitive Advantages

October 09, 2025

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends...

Via StockStory

Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP)

October 05, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at drug development inputs & services stocks,...

Via StockStory

This RH Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗

October 02, 2025

Via Benzinga

Why Medpace (MEDP) Stock Is Trading Lower Today

October 02, 2025

Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 3.2% in the morning session after Barclays downgraded the stock to "Underweight" from "Equal-Weight" and reduced its price...

Via StockStory

Breaking Down Medpace Hldgs: 10 Analysts Share Their Views ↗

October 02, 2025

Via Benzinga

1 Healthcare Stock with Exciting Potential and 2 We Ignore

September 29, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This...

Via StockStory

Topics Stocks

Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025

September 23, 2025

From Medpace Holdings, Inc.

Via Business Wire

2 Profitable Stocks with Exciting Potential and 1 We Turn Down

September 15, 2025

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

Topics Regulatory Compliance

Medpace Hldgs Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) ↗

September 03, 2025

Via Benzinga

This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗

September 03, 2025

Via Benzinga

2 Mooning Stocks to Target This Week and 1 That Underwhelm

September 02, 2025

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Via StockStory

2 Cash-Producing Stocks on Our Watchlist and 1 We Turn Down

August 27, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

2 Reasons to Watch MEDP and 1 to Stay Cautious

August 22, 2025

Medpace currently trades at $450.01 and has been a dream stock for shareholders. It’s returned 266% since August 2020, more than tripling the S&P 500’s 85.3% gain. The company has also beaten the index...

Via StockStory

Topics Stocks Supply Chain

3 Market-Beating Stocks with Competitive Advantages

July 31, 2025

Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the...

Via StockStory

Why Medpace (MEDP) Stock Is Trading Lower Today

July 29, 2025

Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 3.3% in the morning session after UBS downgraded the stock to 'Sell' from 'Neutral', sending shares lower. The investment bank...

Via StockStory

Uber To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

July 29, 2025

Via Benzinga

Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio? ↗

July 27, 2025

Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance.

Via Benzinga

Topics Earnings

Stocks making big moves this week: Cal-Maine, Skillz, TransUnion, Medpace, and Bruker

July 25, 2025

Check out the companies making headlines this week:

Via StockStory

Medpace (MEDP) Stock Trades Down, Here Is Why

July 23, 2025

Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 7.5% in the afternoon session after an analyst at TD Cowen downgraded the stock to "Sell" from "Hold," citing valuation concerns...

Via StockStory

This Centene Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗

July 23, 2025

Via Benzinga

Stocks making big moves yesterday: Vital Farms, Robinhood, Simmons First National, Medpace, and Azenta

July 23, 2025

Check out the companies making headlines yesterday:

Via StockStory

Demystifying Medpace Hldgs: Insights From 4 Analyst Reviews ↗

July 23, 2025

Via Benzinga

Medpace Beats Q2 Revenue Estimates ↗

July 22, 2025

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.